Hyperkeratosis

DBCOND0020030Skin and Subcutaneous Tissue Diseases

Hyperkeratosis is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.

Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT201059003MedDRA10020648UMLSC0022593

What you can answer from here — as of October 21, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
14Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Hyperkeratosis share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In